Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors
US8431594B2 · kind B2 · utility
10Cited by
8References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2009 |
| Grant date | Apr 30, 2013 |
| Priority date | — |
| Expiry date | Jul 26, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D237/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Bridged bicyclic heteroaryl substituted triazoles and pharmaceutical compositions containing the compounds are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase AxI. Methods of using the compounds in treating diseases or conditions associated with AxI activity are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.